Teduglutide 1.25mg powder and solvent for solution for injection vials

in short Teduglutide 1.25mg inj vials

SNOMED code
35084211000001104
Active compound
Teduglutide
Preferred name basis
rINN - Recommended International Non-proprietary
Prescribable
✅ Yes
Dose form
Discrete
Dose size and units
1 vial, vial
Ingredients
Teduglutide — 1.3 mg based on ingredient substance
Form & Route
solutioninjection.subcutaneous
Powder and solvent for solution for injection, Subcutaneous
Controlled drug
No Controlled Drug Status

Products

Revestive 1.25mg powder and solvent for solution for injection vials (Takeda UK Ltd)

in short Revestive 1.25mg inj vials

Revestive 1.25mg powder and solvent for solution for injection vials

SNOMED code
35084311000001107
Supplier
Takeda UK Ltd
Licensed as
Medicines - MHRA/EMA
EMA (European Medicines Agency) Monitoring
Yes, black triangle marked
Availability restrictions
None
Licensed route
Subcutaneous
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Revestive 1.25mg powder and solvent for solution for injection vials (Takeda UK Ltd) 28 vial
35084511000001101   ref. pack
💯 Available

Legal category: POM
5060147022063
NHS Indicative Price
£7,307
• Hospital
  • • Prescription Charges

Reference packs

Teduglutide 1.25mg powder and solvent for solution for injection vials 28 vial
SNOMED code
35084411000001100
Quantity and unit
28 vial
Packs